Baxter International Inc
- Last sale
- Nov 12, 2026 · -2.28%
- Market cap
- $13.31B
- 517.35M shares
- Filings
- 1,042
Q3 2026+5.7% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2025derived−42.1% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+11.5% FY25 yoy
- $13.31B
- —
- 1.1×
- 2.0×
- —
- 0.77%
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $11,244,000,000 | reported | |
| FY 2024 | 2024-12-31 | $10,636,000,000 | reported | |
| FY 2023 | 2023-12-31 | $10,360,000,000 revised | reported | |
| FY 2022 | 2022-12-31 | $10,057,000,000 revised | reported | |
| FY 2021 | 2021-12-31 | $12,146,000,000 revised | reported | |
| FY 2020 | 2020-12-31 | $11,673,000,000 | reported | |
| FY 2019 | 2019-12-31 | $11,362,000,000 | reported | |
| FY 2018 | 2018-12-31 | $11,099,000,000 revised | reported | |
| FY 2017 | 2017-12-31 | $10,584,000,000 revised | reported | |
| FY 2016 | 2016-12-31 | $10,163,000,000 | reported | |
| FY 2015 | 2015-12-31 | $9,968,000,000 | reported | |
| FY 2014 | 2014-12-31 | $10,719,000,000 revised | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $348.00M | — | $348.00M | $0.52 | 514.49M sh | +0.6% | 104.8% |
| FY2024 | $590.00M | $0.00 | $590.00M | $1.04 | 511.62M sh | +0.7% | 103.0% |
| FY2023 | $586.00M | $0.00 | $586.00M | $1.16 | 507.83M sh | +0.6% | 45.3% |
| FY2022 | $573.00M | $32.00M | $605.00M | $1.15 | 504.67M sh | +0.5% | 72.5% |
| FY2021 | $530.00M | $600.00M | $1.13B | $1.09 | 502.29M sh | −0.6% | 73.8% |
Segments
LineFY2025ShareChange
Medical Products & Therapies$5.30B47%+1.8%
Healthcare Systems & Technologies$3.07B27%+4.1%
Pharmaceuticals$2.49B22%+3.4%
APAC———
Americas———
EMEA———
Hillrom———
Kidney Care———
Total$11.24B
Surgical & medical instruments & apparatus
Baxter International Inc is the 6th largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
MDLNMedline Inc.$28.4B11.5%4.1%$52.6BSYKStryker Corp$25.1B11.2%12.9%$118.9BMMM3M Co$24.9B1.5%13.0%$96.4BBDXBecton Dickinson & Co$21.8B8.2%7.7%$58.8BBSXBoston Scientific Corp$20.1B19.9%14.4%$64.1B
BAXBaxter International Inc (this company)$11.2B5.7%8.5%$13.3B
SOLVSolventum Corp$8.3B0.9%18.7%$15.1BRMDResmed Inc$5.7B9.9%26.9%$33.6BDXCMDexCom Inc$4.7B15.6%17.9%$30.4BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Baxter International Inc · CIK 10456 · Engraved from SEC EDGAR